Decomit Inhaler
Beclomethasone Dipropionate Nasal prep
250mcg
Beximco Pharmaceuticals Ltd.
| Pack size | 1 |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 240.00 NPR |
Available as:
Indications
Decomit Inhaler is used for:
Sinusitis, Hay fever, Allergic and non-allergic rhinitis, Nasal Polyps (Postsurgical Prophylaxis), Vasomotor Rhinitis
Adult Dose
Adults: The usual dosage is 1-2 inhalations in each nostril twice a day .
Child Dose
Children 12 Years of Age and Older: The usual dosage is 1-2 inhalations in each nostril twice a day .
Children 6 to 12 Years of Age: Patients should be started with 1 inhalation in each nostril twice a day;
patients with more severe symptoms may use 2 inhalations in each nostril.
<6 years: Safety and efficacy not established
Renal Dose
Administration
Shake well before each use
Before first use, prime pump by 6 actuations into air
If not used for 7 days, reprime pump until fine spray appears
Contra Indications
patients with a history of hyper-sensitivity to any of the components
Precautions
Nasal passage infections and paranasal sinuses should be appropriately treated.
Caution should be exercised whilst transferring patients from systemic steroid treatment to Beclometasone Dipropionate Aqueous Nasal Spray if there is doubt that their adrenal function is impaired.
Systemic effects of nasal corticosteroids may occur particularly at high doses prescribed for prolonged periods. Growth retardation has been reported in children receiving nasal corticosteroids at licensed doses.
Treatment with higher than recommended doses may result in clinically significant adrenal suppression. If there is evidence for higher than recommended doses being used then additional systemic corticosteroid cover should be considered during periods of stress or elective surgery.
Lactation: Unknown whether distributed in breast milk; use caution
Pregnancy-Lactation
Interactions
Adverse Effects
Side effects of Beclomethasone Dipropionate Nasal prep :
>10%
Nasopharyngeal irritation (24%)
1-10%
Headache (<5%),Nausea (<5%),Lightheadedness (<5%),Sneezing attacks after administration (4%),Nasal congestion (<3%),Nose bleeds (<3%),Rhinorrhea (<3%),Increased lacrimation (<3%),Epistaxis (<3%)
Frequency Not Defined
Nasal mucosa ulceration,Nasal septum perforation
Mechanism of Action
Beclometasone controls the rate of protein synthesis, depresses the migration of polymorphonuclear leukocytes, fibroblasts, reverses capillary permeability and lysosomal stabilisation at the cellular level to prevent or control inflammation.
Note
Decomit 250mcg Inhaler manufactured by Beximco Pharmaceuticals Ltd.. Its generic name is Beclomethasone Dipropionate Nasal prep. Decomit is availble in Nepal.
Farmaco Nepal drug index information on Decomit Inhaler is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.